<DOC>
	<DOC>NCT00719511</DOC>
	<brief_summary>Evaluation of patch as specific immunotherapy in allergic patients</brief_summary>
	<brief_title>Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: Written informed consent History of grass pollen allergic rhinitis Male and female between 18 years to 65 years Positive skinprick test to grass pollen Positive conjunctival provocation test Exclusion criteria: Eczematous skin lesions on the upper arms Perennial allergic rhinitis Symptoms of infectious disease with rhinitis in between the last 2 weeks Surgical intervention in between the last 30 days Pregnancy or nursing History of HIV or AIDS History of mastocytosis (cutaneous or systemic) History of significant cardiovascular disease Hypertension (blood pressure &gt; 160 / 95) History of significant pulmonary, renal and/or hepatic disease History of significant hematological disorder Moderate or severe asthma History of malignancy History of neurological or psychiatric disease History of autoimmune disease Antihistamines with longed halflives in the last week Systemic or topical steroids for 5 days Active infectious disease Contraindicated medications: immunosuppressive agents Betablockers ACEinhibitors, AT 2 Antagonists tricyclic antidepressants daily use of Betaagonists or steroid inhalers Participation in another clinical trial /study at the moment or within the last 60 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Rhinoconjunctivitis</keyword>
	<keyword>Allergic</keyword>
</DOC>